Skip to main content
MDA $35.21 +1.15%
MDA logo

MDA · MDA Space Ltd.

Track MDA — free
$35.21 +0.40 (+1.15%) At close · Aug 14
Market Cap
$5.71B
Shares
162.06M
All earnings calls

Earnings call · FY2025 Q4

MDA Space Ltd. Q4 FY2025 Earnings Call

MDA Space Ltd. Q4 FY2025 Earnings Call

Concluded Dec 31, 2025
Dec 31, 2025 63 turns
Period
FY2025 Q4
Runtime
Sources
1 artifact

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Revenue and earnings growth 50 49North non-space defense business 19 2026 financial outlook 18 Defense and government contracts 16 R&D and innovation 11 Canadian defense and NATO spending 8

Management tone

Confident

Net tone +78 · low hedging

Grounding quotes
  • “Our backlog of $4 billion at the end of 2025 provides us with strong revenue visibility.”
  • “In 2025, we delivered record results for both revenue and adjusted EBITDA. We grew revenues to $1.6 billion, an increase of more than 50% year-over-year and expanded our adjusted EBITDA to $324 million, up almost 50% versus last year.”
  • “And lastly, we expect free cash flow to be neutral to negative for the full year due to normal working capital fluctuations on our existing programs and continued investments in growth CapEx.”
  • “We expect full year adjusted EBITDA to be $320 million to $370 million, representing year-over-year growth of approximately 7% at the midpoint, with adjusted EBITDA margin of 18% to 20%, in line with our original IPO guidance.”

Forward guidance

4 guided metrics

Management's latest ranges and targets are included below.

Research coverage

1 live source

Switch sources without leaving this page or losing your listening position.

Research materials

Open the source you need; every reader stays inside this workspace.

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
Revenues
full year
$1.7B – $1.9B
Adjusted EBITDA
full year
$320M – $370M
Adjusted EBITDA margin
full year
18% – 20%
Capital expenditures
full year
$225M – $275M
Full-screen source Call document